The Representative Office of Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd in Vietnam (Takeda RO Vietnam) was set up in Ho Chi Minh City in Nov 2014. Takeda RO Vietnam is part of the VIMAS cluster that includes Vietnam, Malaysia and Singapore. Strategic pillars of Vietnam are aligned to global therapeutic areas of focus on Gastro-enterology and Oncology. We have been able to respond to the unmet needs of patients with our current PPI (proton pump inhibitor) portfolio and will work to continue to serve GI patients with the recent launch of Dexilant.
Our credo is to aim for “Better Health, Better Future” for Vietnamese patients.
Contact us at VietnamCommunications@takeda.com